| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 8,365 | 12,578 | 12,706 | 12,101 | | Cost of Revenue | 2,151 | 2,439 | 2,386 | 2,496 | | | Gross Profit |
-
| 10,139 | 10,320 | 9,605 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 5,334 | 6,480 | 5,225 | 5,483 | | Non Recurring | (2,288) | 2,128 | (1,010) | 1,170 | | Others | 3,128 | (940) | 7,394 | 1,369 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss |
-
| 2,471 | (1,289) | 1,583 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 40 | 2,471 | (1,289) | 1,583 | | Interest Expense | 989 | 979 | 999 | 1,065 | | Income Before Tax | (949) | 1,492 | (2,288) | 518 | | Income Tax Expense | (680) | 434 | (896) | 157 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (269) | 1,058 | (1,392) | 361 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (269) | 1,058 | (1,392) | 361 | | Preferred Stock And Other Adjustments | (256) | (289) | (227) |
-
| | | Net Income Applicable To Common Shares | ($525) | $769 | ($1,619) | $361 |
|
0.43% Nasdaq 
0.08 (1.89%) 
Income Statement
